Half-Life (t1/2)

Understand how half-life emerges from clearance and volume, and how to interpret it correctly.
Tip

What you’ll build today: a clear understanding that half-life is not independent—it emerges from clearance and volume.

Learning Objectives

By the end of this lesson, you will be able to:

  • Define half-life conceptually
  • Explain how clearance and volume determine half-life
  • Interpret changes in half-life correctly
  • Avoid common misinterpretations of half-life

Key Ideas

Half-life describes:

how long it takes for concentration to decrease by half

But critically:

Half-life is not an independent property

It is determined by clearance and volume.

The Core Relationship

\[ t_{1/2} = \frac{0.693 \cdot V}{CL} \]

Insight: Half-life depends on both how drug is removed (CL) and how it is distributed (V).

A Useful Mental Model

Think of half-life as a balance:

flowchart LR

V["Volume (stores drug)"]
-->
HL["Half-life"]

CL["Clearance (removes drug)"]
-->
HL

  • larger V → longer persistence
  • larger CL → shorter persistence

Worked Example: Different Paths to Different Half-Lives

Notice:

  • increasing V lengthens half-life
  • increasing CL shortens half-life

Half-life itself does not explain why.

CL and V do.

Expanding the Insight

This leads to one of the most important ideas in pharmacometrics:

Half-life is a result of clearance and volume — not an independent mechanism

That means half-life tells you:

  • how long concentration appears to persist
  • how quickly concentrations decline

But half-life does not tell you:

  • whether persistence comes from slow removal
  • whether persistence comes from wide distribution
  • which underlying process changed

Two systems can even have the same half-life for different reasons.

Example:

Scenario Clearance Volume Half-life
Drug A Low Low Same
Drug B High High Same

Same half-life.

Different biology.

This is why half-life is useful as a summary—but not sufficient for interpretation.

Clinical Interpretation

Half-life is often used for:

  • dosing interval decisions
  • accumulation expectations
  • time to steady state

But:

👉 It must be interpreted alongside CL and V

Insight

A powerful way to think about half-life:

Half-life reflects how long the system “holds onto” drug

But that depends on:

  • how fast it removes it (CL)
  • how widely it distributes it (V)
Note

Always ask: “Is half-life changing because of clearance, volume, or both?”

Strategies

  • Always interpret half-life with CL and V together
  • Consider whether changes are driven by clearance or distribution
  • Use half-life as a summary, not a mechanistic explanation
  • Be cautious when data are sparse in terminal phase

Common Mistakes

  • Treating half-life as an independent parameter
  • Using half-life alone to make decisions
  • Ignoring underlying CL and V differences
  • Over-relying on half-life for interpretation

Practice Problems

  1. What determines half-life?
  2. Can two systems have the same half-life but different CL and V?
  3. Why is half-life not sufficient on its own?
  1. Clearance and volume
  2. Yes, different combinations can produce the same half-life
  3. Because it does not reveal the underlying mechanisms

Summary

Half-life is:

  • a useful summary
  • but not a fundamental driver

It emerges from:

  • clearance
  • volume

Understanding this relationship is essential for correct interpretation.

  • t½ depends on CL and V
  • Same t½ ≠ same system
  • Half-life is descriptive, not causal
  • Always interpret with CL and V
  • Ask what is driving the change